A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

NCT05811351 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Geographic Atrophy

Interventions

DRUG: JNJ-81201887
DRUG: Prednisone
OTHER: Placebo
DRUG: Triamcinolone
OTHER: Sham Procedure

Sponsor

Janssen Research & Development, LLC